EPIDEMIOLOGY OF KAPOSI'S SARCOMA NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


EPIDEMIOLOGY OF KAPOSI'S SARCOMA

Kaposi's Sarcoma: A Text and Atlas. Gottlieb GJ, Ackerman AB, eds. Philadelphia, Lea and Febiger, p. 255-69, 1988.. Unique Identifier : AIDSLINE ICDB/88647206
Collier AC; Handsfield EH; Dept. of Medicine, Univ. of Washington Sch. of Medicine, Seattle,; WA

Abstract: The epidemiology of Kaposi's sarcoma (KS) is reviewed under the following headings: clinical classification, incidence and geographic distribution, age distribution, sex distribution, ethnic and genetic associations, associations between immunodeficiency and neoplasia, association with cytomegalovirus, and acquired immunodeficiency syndrome (AIDS). Although originally thought to be a rare disease in Europe and worldwide, it became clear by the 1960s that KS was a common health problem in certain regions of subsaharan Africa. The occurrence of KS in iatrogenically immunosuppressed patients was increasingly recognized in the 1970s. The current epidemic of KS in homosexual men and increasingly in heterosexual men and women who have AIDS underscores the need to further understand this multifaceted disease. (131 Refs)
Keywords: Acquired Immunodeficiency Syndrome/MORTALITY Africa Cross-Sectional Studies Cytomegalovirus Infections/MORTALITY Human Sarcoma, Kaposi's/*MORTALITY Skin Neoplasms/*MORTALITY MONOGRAPH REVIEW, TUTORIAL REVIEW

KWDacquiredimmunodeficiencysyndrome/mortalityafricacross-sectionalstudiescytomegalovirusinfections/mortalityhumansarcoma,kaposi's/KWDmortalityskinneoplasms/KWDmortalitymonographreview,tutorialreview
881130
M88B0595

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .